Morphological and morphometric studies of the splenic antitumor immune response, elicited by liposome-covered soluble p53 kDa antigen, in chemically-induced rat colon cancer

International Journal of Molecular Medicine

Volumn 3, Issue 5, 1999, Pages 545-549

  Ben Hur, H ^a,b   Plonsky, E ^b,c   Gurevich, P ^a   Berman, V ^b   Tendler, Y ^a,c   Moriel, E ^a,b,c   Guy, M ^a,b   Sandler, B ^b,c   Rozenberg, V ^a,b   Zusman, R ^a,c   Zusman, I ^a,b  

^a KAPLAN MEDICAL CENTER   (Israel)

^b HEBREW UNIVERSITY OF JERUSALEM   (Israel)

^c RAMBAM MEDICAL CENTER   (Israel)

Author keywords

Colon cancer; Liposomes; Lymph system; Resistance; Soluble 53 kda protein; Spleen

Indexed keywords

AZOXYMETHANE; CARCINOGEN; LIPOSOME; PROTEIN P53;

ANIMAL; ARTICLE; COLON TUMOR; IMMUNOLOGY; MALE; PATHOLOGY; RAT; SOLUBILITY; SPLEEN; SPRAGUE DAWLEY RAT; VACCINATION;

ANIMALS; AZOXYMETHANE; CARCINOGENS; COLONIC NEOPLASMS; LIPOSOMES; MALE; RATS; RATS, SPRAGUE-DAWLEY; SOLUBILITY; SPLEEN; TUMOR SUPPRESSOR PROTEIN P53; VACCINATION;

EID: 0033125556     PISSN: 11073756     EISSN: None     Source Type: Journal    
DOI: 10.3892/ijmm.3.5.545     Document Type: Article

References (17)

1. Zusman I, Gurevich P, Sandler B, Zusman R, Smirnoff P and Tendler Y: Tumor-suppressor effects of anti-p53 IgG on chemically induced colon cancer in rats. Cancer J 10: 116-120, 1997.
2. Zusman I, Zusman R, Gurevich P, Korol D and Tendler Y: High tumor-preventive effects of polyclonal IgG generated against p53 tumor-associated protein obtained from benign-tumor bearing rats. Oncol Rep 3: 975-979, 1996.
3. Ben-Hur H, Ben-Meir A, Ben-Arie A, Hagay Z, Berman V, Schwartsburd B, Gurevich P, Sandier B, Tendler Y, Zinder O and Zusman I: Tumor-suppressor effects of the soluble p53 antigen on chemically-induced skin cancer in mice. Anticancer Res 18B: 4237-4242, 1998.
4. Ben-Hur H, Gurevich P, Hagay Z, Berman V, Tendler Y, Sandier B, Zinder O and Zusman I: Immune response of rat spleen cells to a carcinogen and to vaccination with anti-p53 polyclonal antibodies. Anticancer Res 18: 273-282, 1998.
5. Xu M, Kumar D, Srinivas S, Detolla LJ, Yu SF, Stass SA and Mixson AJ: Parenteral gene therapy with p53 inhibits human breast tumors in vivo through a bystander mechanism without evidence of toxicity. Hum Gene Ther 8: 177-185, 1997.
6. Zusman I, Zusman R, Korol D, Sandier B, Ben-Hur H, Bass D, Mashiah A, Lifschitz-Mercer B, Smirnoff P and Glick J: Isolation of p53 protein from the serum of colon cancer and non-cancer patients. Oncol Rep 2: 679-683, 1995.
7. Gurevich P, Czernobilsky B, Ben-Hur H, Nyska A, Zuckerman A and Zusman I: Pathology of lymphoid organs in low-birth-weight human fetuses subjected to antigen-induced influences: a morphological and morphometric study. Pediatr Pathol 14: 679-693, 1994.
8. Bergers JJ, Otter WD and Crommelin DJA: Liposome-based cancer vaccines. J Liposome Res 6: 339-355, 1996.
9. Lesson-Wood LA, Kim WH, Kleinman HK, Weintraub BD and Mixson AJ: Systemic gene therapy with p53 reduces growth and metastases of a malignant human breast cancer in nude mice. Hum Gene Ther 6: 395-405, 1995.
10. Xu M, Kumar D, Stass SA and Mixson AJ: Gene therapy with p53 and a fragment of thrombospondin I inhibits human breast cancer in vivo. Mol Genetics Metab 63: 103-109, 1998.
11. + T-cell responses. Immunol Today 17: 409-414, 1996.
12. Laman JD, Claassen E and Noelle RJ: Functions of CD40 and its ligand, gp39 (CD40L). Crit Rev Immunol 16: 59-108, 1996.
13. Zhang J and Russell SJ: Vectors for cancer gene therapy. Cancer Metastasis Rev 15: 385-401, 1996.
14. Oprea M and Perelson AS: Exploring the mechanisms of primary antibody responses to T cell-dependent antigens. J Theor Biol 181: 215-236, 1996.
15. Tendler Y, Ben-Hur H, Gurevich P, Berman V, Sandler B, Nyska A, Zion H, Zinder O and Zusman I: Role of apoptosis, proliferating cell nuclear antigen and p53 protein in the immune response of rat colon cells to cancer and vaccination with anti-p53 polyclonal IgG. Anticancer Res 17: 4653-4658, 1997.
16. Corr M, Lee DJ, Carson DA and Tighe H: Gene vaccination with naked plasmid DNA: mechanism of CTL priming. J Exp Med 184: 1555-1560, 1996.
17. Amano T, Nakazawa M, Oshima T, Bosshardt SC and Colley DG: Cross-reactive idiotypes on rabbit anti-SEA antibodies stimulate antiidiotype spleen and lymph node cell responses of mice infected with Schistosoma mansoni. Parasite Immunol 18: 21-28, 1996.